June 13, 2022 | Sculptra
2 minute read
Sculptra is an FDA-approved facial filler for the correction of shallow to deep nasolabial folds or smile lines, hollow areas of the cheeks and contour deficiencies that has a long history of safety worldwide since 1999.
Sculptra is different from hyaluronic acid fillers. It is known as a Poly-L-Lactic Acid and is considered a bio-activator or “volumizer”. Sculptra works by stimulating the body to produce new collagen at the sites of injection, thereby replacing lost volume and contours to restore a fuller, more youthful appearance. The results are natural looking and appear over a period of a few months.
The newly generated collagen can last two or more years. For maximum effects, 2-3 treatments are recommended. As with all injections, there can be temporary swelling and bruising.
Individuals who want to replace the natural volume loss that occurs as we age, particularly in the cheek area, may be good candidates for Sculptra. The most common age to receive Sculptra injections is between ages 35-65.
Sculptra is also often used in combination with other injectables, laser skin resurfacing or laser skin tightening treatments. Sculptra can also be used as an interim non-surgical step to provide volume and lift to the cheek area. The effects of these combined treatments can be dramatic, while still requiring very little down time for recovery. Sculptra can also be a valuable adjunct to facelift surgery. A facelift will remove excess skin, but a facelift will not restore volume. Consult with a facial plastic surgeon today to determine if you are a good candidate for Sculptra injections.
